DRUG DISCOVERY & DEVELOPMENT
WITH A BETTER ASSESSMENT
OF YOUR COMPOUNDS ON REGULATORY T CELLS

ABOUT US

Immune insighT is a Contract Research Organization (CRO) based In Lille (France) founded in 2016, Spin-off which stems from academic research.

We are specialized in ex-vivo and in-vivo assessment of compounds on the immune system and more specifically regulatory T cells (Tregs).

OUR SCIENCE

Molecular insight

An original Treg Molecular Signature (TregSign kit) which allows, in a single assay, a complete transcriptomic study of Tregs.
KNOW MORE

Cellular insight

A wide range of methods to comprehensively assess the efficacy and safety of your compound of interest on Treg Biology.
KNOW MORE

Animal insight

In vivo assessment of a compound efficacy and safety can be carried out on a human cancer model designed for you (Syngeneic, PDX-Like models…).
KNOW MORE

NEWS

March 2021

Immune insighT will be attending the HYBRID Days : to meet members of the health bioscience research industry - 16th - 17h march 2021

December 2020

Immune insighT participated in the International Biofit conference on 7th – 10th December 2020

November 2020

To stay updated on all the latest trends in cocology treatments, Immune insighT attended to annual PhotoDynamic Therapy and Photo diagnosis E-congress 5th – 6th November 2020

November 2020

Immune insighT is a proud sponsor of the PROVENTA INTERNATIONAL congress :
Online Oncology strategy Meeting (3rd November)
Come meet with us at the Proventa : Online Strategy Meeting.
We will be at the round table discussions surrounding ADCs and ICI in Oncology.

previous arrow
next arrow
Slider

OUR PARTNERS

Scroll to Top